Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)

Autor: Rachel Reed, Sarah Brown, David Buckley, Peter Hoskin, Ananya Choudhury, Ann Henry, Andrew Scarsbrook, Jim Zhong, Catharine West, Maria Serra, Pam Shuttleworth, Peter Bownes, Christopher Thompson, Kimberley Reeves, Michael Dubec, Damien McHugh, Cynthia Eccles, Robert Chuter, Yat Man Tsang, N Jane Taylor

Publikováno v: BMJ Open, Vol 12, Iss 11 (2022)

Introduction Radiotherapy is the most common curative treatment for non-metastatic prostate cancer; however, up to 13% of patients will develop local recurrence within 10 years. Patients can undergo further and potentially curative treatment includin

Externí odkaz: https://doaj.org/article/2096a11b409649fda5984595a7b5bd2c

The impact of an educational tool in cervix image registration across three imaging modalities

Autor: Rebecca Benson, John Rodgers, Claire Nelder, Abigael Clough, Eleanor Pitt, Jacqui Parker, Lee Whiteside, Lucy Davies, Rachael Bailey, John McMahon, Hope Kolbe, Anthea Cree, Michael Dubec, Marcel Van Herk, Ananya Choudhury, Peter Hoskin, Cynthia Eccles

Publikováno v: British journal of radiology, 95(1137):20211402. British Institute of Radiology

Objectives Accurate image registration is vital in cervical cancer where changes in both planning target volume (PTV) and organs at risk (OARs) can make decisions regarding image registration complicated. This work aims to determine the impact of a d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2136299a3651a689fc2ebd4da56075cf
http://www.scopus.com/inward/record.url?scp=85136199241&partnerID=8YFLogxK

Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)

Autor: Jim Zhong, Sarah Brown, Maria Serra, Pam Shuttleworth, Peter Bownes, Christopher Thompson, Rachel Reed, Kimberley Reeves, Michael Dubec, Damien McHugh, Cynthia Eccles, Robert Chuter, Yat Man Tsang, N Jane Taylor, Catharine West, David Buckley, Andrew Scarsbrook, Ananya Choudhury, Peter Hoskin, Ann Henry

Publikováno v: Zhong, J, Brown, S, Serra, M, Shuttleworth, P, Bownes, P, Thompson, C, Reed, R, Reeves, K, Dubec, M, McHugh, D, Eccles, C, Chuter, R, Tsang, Y M, Taylor, N J, West, C, Buckley, D, Scarsbrook, A, Choudhury, A, Hoskin, P & Henry, A 2022, ' Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP) : Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT) ', BMJ Open, vol. 12, no. 11, 068580 . https://doi.org/10.1136/bmjopen-2022-068580

IntroductionRadiotherapy is the most common curative treatment for non-metastatic prostate cancer; however, up to 13% of patients will develop local recurrence within 10 years. Patients can undergo further and potentially curative treatment including

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::378a5906103a91a033272111e3e5079e
https://doi.org/10.1136/bmjopen-2022-068580